Pseudomonas aeruginosa heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa (P. aeruginosa), a common cause of severe chronic infections, has developed heteroresistance to several antibiotics, thus hindering successful treatment. In this study, we aimed to investigate the characteristics and mechanisms underlying levofloxacin (LVX) heteroresistance in P. aeruginosa PAS71 and PAS81 clinical isolates using a combination of physiological and biochemical methods, bacterial genomics, transcriptomics, and qRT-PCR. The six P. aeruginosa strains, namely PAS71, PAS72, PAS81, PAS82, ATCC27853, and PAO1, were studied. The Kirby–Bauer (K–B), minimum inhibitory concentration (MIC) test, and population analysis profile (PAP) experimental results showed that PAS71, PAS81, ATCC27853, and PAO1 were heteroresistant to LVX, with MIC of 0.25, 1, 0.5, and 2 μg/ml, respectively; PAS72 and PAS82 were susceptible to LVX with a MIC of 0.25 and 0.5 μg/ml, respectively. The resistance of PAS71 and PAS81 heteroresistant subpopulations was unstable and had a growth fitness cost. Genomic and transcriptomic results proved that the unstable heteroresistance of PAS71 and PAS81 was caused by elevated expression of essential genes involved in DNA replication and repair, and homologous recombination, rather than their genomic single-nucleotide polymorphism (SNP) and insertion–deletion (InDel) mutations. Additionally, PAS71 and PAS81 enhanced virulence and physiological metabolism, including bacterial secretion systems and biosynthesis of siderophore group nonribosomal peptides, in response to LVX stress. Our results suggest that the upregulation of key genes involved in DNA replication and repair, and homologous recombination causes unstable heteroresistance in P. aeruginosa against LVX. This finding provides novel insights into the occurrence and molecular regulation pathway of P. aeruginosa heteroresistant strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mechanisms controlling unstable heteroresistance in P. aeruginosa are varied and include overexpression of efflux pumps155–157, decreased levels of the OprD porin155,157 and increased expression of genes involved in DNA replication and repair158, among others.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [158]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513
Antimicrobial heteroresistance: An emerging field in need of clarity
El-Halfawy, O. M., & Valvano, M. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-14 · Cited by 489 · cited 3×
“Heteroresistant strains have been defined as heteroresistant subpopulations capable of growth at antibiotic concentrations approximately 8-fold higher than the highest concentration without affecting the dominant population’s growth; they have frequencies greater than 1 × 10−7, according to previous reports (EI-Halfaw…”
BackgroundMethod
Research works printed but not linked: 33
- Albelda-Berenguer, 2019, Siderophores: from natural roles to potential applications, Adv. Appl. Microbiol., 106, 193, 10.1016/bs.aambs.2018.12.001 · DOI · Paper page
- Baaity, 2022, Phenotypic and molecular characterization of carbapenem-heteroresistant Bacteroides fragilis strains, Antibiotics, 11, 590, 10.3390/antibiotics11050590 · DOI
- Balbontín, 2021, DNA breaks-mediated fitness cost reveals RNase HI as a new target for selectively eliminating antibiotic-resistant bacteria, Mol. Biol. Evol., 38, 3220, 10.1093/molbev/msab093 · DOI
- Band, 2019, Heteroresistance: a cause of unexplained antibiotic treatment failure?, PLoS Pathog., 15, e1007726, 10.1371/journal.ppat.1007726 · DOI · Paper page
- Cao, 2020, Mutation-induced remodeling of the BfmRS two-component system in Pseudomonas aeruginosa clinical isolates, Sci. Signal., 13, eaaz1529, 10.1126/scisignal.aaz1529 · DOI
- Carroll, 2018, Ironing out siderophore biosynthesis: a review of non-ribosomal peptide synthetase (NRPS)-independent siderophore synthetases, Crit. Rev. Biochem. Mol. Biol., 53, 356, 10.1080/10409238.2018.1476449 · DOI · Paper page
- 2020, M100. Performance Standards for Antimicrobial Susceptibility Testing, 30th Edn
- Du, 2018, Multidrug efflux pumps: structure, function and regulation, Nat. Rev. Microbiol., 16, 523, 10.1038/s41579-018-0048-6 · DOI · Paper page
- Epshtein, 2014, UvrD facilitates DNA repair by pulling RNA polymerase backwards, Nature, 505, 372, 10.1038/nature12928 · DOI · Paper page
- Francis, 2017, Two-component systems required for virulence in Pseudomonas aeruginosa, FEMS Microbiol. Lett., 364, fnx104, 10.1093/femsle/fnx104 · DOI · Paper page
- Greci, 2022, The combined DNA and RNA synthetic capabilities of archaeal DNA primase facilitate primer hand-off to the replicative DNA polymerase, Nat. Commun., 13, 433, 10.1038/s41467-022-28093-2 · DOI
- Hachani, 2011, Type VI secretion system in Pseudomonas aeruginosa, J. Biol. Chem., 286, 12317, 10.1074/jbc.M110.193045 · DOI · Paper page
- He, 2018, Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections, Int. J. Antimicrob. Ag., 51, 413, 10.1016/j.ijantimicag.2017.10.014 · DOI
- Hooper, 2015, Mechanisms of drug resistance: quinolone resistance, Ann. N. Y. Acad. Sci., 1354, 12, 10.1111/nyas.12830 · DOI · Paper page
- Hooper, 2004, Quinolone antimicrobial agents, Emerg. Infect. Dis., 10, 1177, 10.3201/eid1006.040025 · doi:10.3201/eid1006.040025
- Ikonomidis, 2008, Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa, FEMS Microbiol. Lett., 279, 36, 10.1111/j.1574-6968.2007.00997.x · DOI · Paper page
- Jia, 2020, Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia, Int. J. Antimicrob. Ag., 23, 1, 10.1016/j.ijantimicag.2019.10.013 · DOI
- Kelman, 1995, DNA polymerase III holoenzyme: structure and function of a chromosomal replicating machine, Annu. Rev. Biochem., 64, 171, 10.1146/annurev.bi.64.070195.001131 · DOI · Paper page
- Lam, 2020, Overcoming multidrug resistance and biofilms of Pseudomonas aeruginosa with a single dual-function potentiator of β-lactams, ACS Infect. Dis., 6, 1085, 10.1021/acsinfecdis.9b00486 · DOI
- Lee, 2015, Preservation of acquired colistin resistance in Gram-negative bacteria, Antimicrob. Agents Chemother., 60, 609, 10.1128/AAC.01574-15 · DOI
- Li, 2021, Diallyl sulfide from garlic suppresses quorum-sensing systems of Pseudomonas aeruginosa and enhances biosynthesis of three B vitamins through its thioether group, Microb. Biotechnol., 14, 677, 10.1111/1751-7915.13729 · DOI
- Lin, 2019, Resistance and hetero-resistance to colistin in Pseudomonas aeruginosa isolates from Wenzhou, China, Antimicrob. Agents Chemother., 63, e00556-19, 10.1128/AAC.00556-19 · DOI · Paper page
- Millan, 2015, Interactions between horizontally acquired genes create a fitness cost in Pseudomonas aeruginosa, Nat. Commun., 6, 6845, 10.1038/ncomms7845 · DOI · Paper page
- Namsaraev, 1998, Biochemical basis of hyper-recombinogenic activity of Pseudomonas aeruginosa RecA protein in Escherichia coli cells, Mol. Microbiol., 27, 727, 10.1046/j.1365-2958.1998.00718.x · doi:10.1046/j.1365-2958.1998.00718.x
- Nicoloff, 2019, The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification, Nat. Microbiol., 4, 504, 10.1038/s41564-018-0342-0 · DOI · Paper page
- Pacheco, 2017, Metabolic compensation of fitness costs is a general outcome for antibiotic-resistant Pseudomonas aeruginosa mutants overexpressing efflux pumps, MBio, 8, e00500, 10.1128/mBio.00500-17 · DOI
- Pi, 2020, Fitness cost and compensatory evolution in levofloxacin-resistant Mycobacterium aurum, Antimicrob. Agents Chemother., 64, e00224, 10.1128/AAC.00224-20 · doi:10.1128/aac.00224-20
- Roberts, 2015, Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant gram-negative bacteria, ACS Infect. Dis., 1, 568, 10.1021/acsinfecdis.5b00085 · DOI
- Roy, 2009, SSB diffusion on single stranded DNA stimulates RecA filament formation, Nature, 461, 1092, 10.1038/nature08442 · DOI
- Sana, 2016, The T6SSs of Pseudomonas aeruginosa strain PAO1 and their effectors: beyond bacterial-cell targeting, Front. Cell Infect. Microbiol., 6, 61, 10.3389/fcimb.2016.00061 · DOI · Paper page
- Swietnicki, 2019, Identification of a potent inhibitor of type II secretion system from Pseudomonas aeruginosa, Biochem. Bioph. Res. Communicat., 513, 688, 10.1016/j.bbrc.2019.04.055 · DOI · Paper page
- Tam, 2005, Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 49, 3624, 10.1128/AAC.49.9.3624-3630.2005 · DOI · Paper page
- Wang, 2019, Salicylate increases fitness cost associated with MarA-mediated antibiotic resistance, Biophys. J., 117, 563, 10.1016/j.bpj.2019.07.005 · DOI
Cited by
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
Metadata
- Authors
- Li, W.-R., Zhang, Z.-Q., Liao, K., Wang, B.-B., Liu, H.-Z., Shi, Q.-S., Huang, X.-B., & Xie, X.-B.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-23
- Volume
- 13
- ISSN
- 1664-302X
- Cited by
- 17
- References
- 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pseudomonas aeruginosa heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair. https://app.cochat.ai/papers/10.3389/fmicb.2022.1105921
- The paper
- Li, W.-R., Zhang, Z.-Q., Liao, K., Wang, B.-B., Liu, H.-Z., Shi, Q.-S., Huang, X.-B., & Xie, X.-B. (2022). Pseudomonas aeruginosa heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2022.1105921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.